Open Access. Powered by Scholars. Published by Universities.®
- Institution
-
- Ohio Northern University (6)
- Wayne State University (4)
- Roseman University of Health Sciences (3)
- Arcadia University (2)
- LSU Health New Orleans (2)
-
- Marshall University (2)
- University of Kentucky (2)
- Valparaiso University (2)
- Abilene Christian University (1)
- City University of New York (CUNY) (1)
- Fort Hays State University (1)
- HCA Healthcare (1)
- JSS Academy of Higher Education and Research (1)
- Liberty University (1)
- Louisiana State University (1)
- Philadelphia College of Osteopathic Medicine (1)
- Sacred Heart University (1)
- Thomas Jefferson University (1)
- United Arab Emirates University (1)
- University of Missouri, St. Louis (1)
- University of North Dakota (1)
- University of San Diego (1)
- University of Texas at Arlington (1)
- Virginia Commonwealth University (1)
- Western University (1)
- Wright State University (1)
- Keyword
-
- Depression (5)
- CBT (2)
- Citalopram (2)
- Fluoxetine (2)
- Neuroscience (2)
-
- OCD (2)
- PTSD (2)
- Paroxetine (2)
- Pregnancy (2)
- Psychosis (2)
- Schizophrenia (2)
- Serotonin Uptake Inhibitors (2)
- Sertraline (2)
- "HDRS" (1)
- "Hamilton Depression Rating Scale" (1)
- "Intramuscular Ketamine" (1)
- "Quality Improvement" (1)
- "Treatment Resistant Depression" (1)
- 5 A's (1)
- 7-OH (1)
- 7-OH ban (1)
- ABCBl Protein (1)
- ADHD medication abuse (1)
- ASD; ADHD; PDD-NOS; Asperger Syndrome; Autistic Disorder; Hyperactivity; Stimulants; MPH; Guanfacine; Clonidine (1)
- Abortion (1)
- Addiction (1)
- Adjunctive therapy (1)
- Adolescence (1)
- Adolescent (1)
- Adverse effects (1)
- Publication Year
- Publication
-
- Pharmacy and Wellness Review (6)
- Annual Research Symposium (3)
- Clinical Research in Practice: The Journal of Team Hippocrates (3)
- Capstone Showcase (2)
- Journal of Mind and Medical Sciences (2)
-
- Marshall Journal of Medicine (2)
- School of Medicine Faculty Publications (2)
- Academic Leadership Journal in Student Research (1)
- Best Integrated Writing (1)
- Capstones (1)
- DNP Projects (1)
- Department of Pharmacology and Experimental Therapeutics Faculty Papers (1)
- Digital Journal of Clinical Medicine (1)
- Dissertations (1)
- Doctor of Nursing Practice Final Manuscripts (1)
- Electronic Theses and Dissertations (1)
- Graduate Research Posters (1)
- HCA Healthcare Journal of Medicine (1)
- LSU Doctoral Dissertations (1)
- Medical Student Research Symposium (1)
- PCOM Physician Assistant Studies Student Scholarship (1)
- Physician Assistant Scholarly Project Posters (1)
- Physician Associate Studies Faculty Publications (1)
- Psychiatry Presentations (1)
- Senior Honors Theses (1)
- Social Work Dissertations - Archive (1)
- Theses and Dissertations--Pharmacy (1)
- Thesis/ Dissertation Defenses (1)
- Publication Type
- File Type
Articles 31 - 41 of 41
Full-Text Articles in Medical Pharmacology
Neonatal Abstinence Syndrome From Selective Serotonin Reuptake Inhibitor Use During Pregnancy, Elizabeth Kramer, Maria Patnella, Rachel Bulko, Allie Harrison, Hannah Lamb, Manoranjan D'Souza
Neonatal Abstinence Syndrome From Selective Serotonin Reuptake Inhibitor Use During Pregnancy, Elizabeth Kramer, Maria Patnella, Rachel Bulko, Allie Harrison, Hannah Lamb, Manoranjan D'Souza
Pharmacy and Wellness Review
Neonatal abstinence syndrome (NAS) is a concern for infants born to mothers receiving treatment with a selective serotonin reuptake inhibitor (SSRI) throughout the pregnancy. The risk of NAS associated with SSRI use during pregnancy varies with the specific SSRI that is used by the patient during pregnancy. Common symptoms of NAS include premature delivery, gastrointestinal disturbances, irritability, low birth weight, short length and lack of response to various stimuli. Neonates that present with these symptoms can be scored using either the Finnegan or Lipsitz scoring tools. Neonates experiencing NAS can be calmed or treated using nonpharmacologic methods such as swaddling, …
Pharmacogenetics: Cyps, Nat2 And 5-Htt Related To Antidepressants, Molly Kulp, Armond Cosiano, Kevin Krivanek, Amanda Lanker, Taylor Roberson, David F. Kisor
Pharmacogenetics: Cyps, Nat2 And 5-Htt Related To Antidepressants, Molly Kulp, Armond Cosiano, Kevin Krivanek, Amanda Lanker, Taylor Roberson, David F. Kisor
Pharmacy and Wellness Review
Pharmacogenetics (PGt), the study of a gene's influence on patient response to a drug, shows strong potential for explaining issues with efficacy related to antidepressant medications. Each year, antidepressants are one of the most commonly prescribed medications due to the millions of Americans affected by depression. Importantly, it is recognized that there is wide interpatient variability in drug response to antidepressants caused by genetic mutations, which can alter the pharmacodynamic (PD) and pharmacokinetic (PK) properties of various drugs used to treat depression. Proteins that are mainly involved in how patients respond to medications include receptors, drug-targeted proteins, drug transport proteins …
A Review Of The Guidelines And Treatment Options For Major Depressive Disorder In Adolescents, Stacy Henthorne, Joy Hoffman, Albert Bui, Sarah Kradel, Suzanne M. Lifer, Mary Ellen Hethcox
A Review Of The Guidelines And Treatment Options For Major Depressive Disorder In Adolescents, Stacy Henthorne, Joy Hoffman, Albert Bui, Sarah Kradel, Suzanne M. Lifer, Mary Ellen Hethcox
Pharmacy and Wellness Review
Major depressive disorder (MOD) is a disease often underdiagnosed in adolescents. For adolescents in particular, MOD can have far-reaching implications on developmental, social and emotional functioning. Unfortunately, few guidelines detail consistent means by which to evaluate and treat these patients; significantly more information exists that solely pertains to the adult population. Governing bodies such as the American Academy of Child and Adolescent Psychiatry (AACAP) and Resource for Advancing Children's Health (REACH) recommend that primary care physicians be diligent in their psychiatric analyses and follow-ups with young patients who may be experiencing MOD. Both psychotherapy and medications, either as monotherapy or …
Antidepressant Therapy: A Review Of Current Treatment Options And A Glance At The Future, Brittany Dye, Stacy Henthorne, Molly Kulp, Tristan Maiers, Zachary Crawford, Erin Petersen
Antidepressant Therapy: A Review Of Current Treatment Options And A Glance At The Future, Brittany Dye, Stacy Henthorne, Molly Kulp, Tristan Maiers, Zachary Crawford, Erin Petersen
Pharmacy and Wellness Review
Depression and anxiety disorders are two of the most common mental illnesses experienced by people within the United States, affecting 6.7 percent of the adult population per year. This article will focus on one specific type of depression, major depressive disorder (MDD), characterized by two or more weeks of depressed mood and/or decreased interest in normally enjoyed activities. Depression complicates treatment of other disease state(s), making successful treatment of depression essential in the management of a patient's overall health. This review will evaluate the pathophysiology, antidepressant treatment, and new approaches to treatment, specifically vortioxetine, for MDD.
Pharmacotherapy For Impulsivity-Hyperactivity Behaviors In Autism Spectrum Disorder, Jenna Katnis
Pharmacotherapy For Impulsivity-Hyperactivity Behaviors In Autism Spectrum Disorder, Jenna Katnis
Physician Assistant Scholarly Project Posters
Hyperactivity is a shared behavior with ASD and Attention Deficit Hyperactivity Disorder (ADHD). Medications such as Methylphenidate (MPH) and α 2-a adrenergic receptor agonists are used to modify hyperactivity behavior in ADHD and thus have been used as management in ASD. A review of literature was done to evaluate the use of medications typically used for ADHD in the use of ASD. The databases searched included PubMED, PsycINFO, Cochrane, and Clinical Key. After reviewing the literature, it was found that both MPH and 2-a adrenergic receptor agonist have a potential role in pharmacotherapy for ASD. MPH may be slightly more …
Post-Traumatic Stress Disorder: Review Of Dsm Criteria And Functional Neuroanatomy, Cornelius W. Thomas
Post-Traumatic Stress Disorder: Review Of Dsm Criteria And Functional Neuroanatomy, Cornelius W. Thomas
Marshall Journal of Medicine
The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for post-traumatic stress disorder (PTSD) consist of over twenty possible symptoms that can be divided into six broad categories. These categories correlate with specific brain networks that regulate emotions, behaviors, and autonomic function. Normal functioning of these networks depends on two key regions; the prefrontal cortex and the amygdala. The prefrontal cortex provides top-down executive control over amygdala, whereas the amygdala is critical for threat detection and activation of the ‘fight or flight’ response. Events that trigger extreme and/or prolonged fear can cause persisting dysregulation within the prefrontal-amygdala circuit; resulting …
Development And Preclinical Evaluation Of Long-Lasting Cocaine Hydrolases For Cocaine Overdose And Cocaine Use Disorder Treatment, Ting Zhang
Theses and Dissertations--Pharmacy
Cocaine is a plant-based illicit drug commonly involved in substance use disorder. Although cocaine overdose and cocaine use disorders cause adverse health consequences to individuals and the economic burden on their family and society, there are no FDA (Food and Drug Administration) approved medications for treatment. Recently, it has been recognized that delivery of cocaine hydrolase (CocH) is a promising therapeutic strategy. Human butyrylcholinesterase (hBChE), the primary enzyme involved in cocaine metabolism in human, have advantages over other candidates for the development of CocH. Previous studies in our laboratory have designed and characterized hBChE mutants that have ~4,000-fold improved catalytic …
Finasteride As A Model For Personalized Medicine, Ion G. Motofei, David L. Rowland, Ioana Păunică, Octavian C. Tănăsescu, Petrişor Banu, Stana Păunică
Finasteride As A Model For Personalized Medicine, Ion G. Motofei, David L. Rowland, Ioana Păunică, Octavian C. Tănăsescu, Petrişor Banu, Stana Păunică
Journal of Mind and Medical Sciences
The side effects of Finasteride are currently a subject of controversy. Some studies report minor or acceptable adverse effects, which decrease after a variable period of time so that they do not necessitate terminating Finasteride administration. However, several clinical and neuro-endocrine studies show that some adverse effects persist indefinitely in the form of post-Finasteride syndrome, even after the drug cessation. This paper presents a possible explanation for these inconsistent findings. First, the study design of either informing or not informing patients prior therapy about possible adverse effects can influence the incidence and magnitude of reported adverse effects. Second, structural and …
Is Pramipexole Safe And Effective In Reducing Depressive Symptoms In Patients With Mild To Moderate Parkinson’S Disease And Depression?, Corinne J. Kern
Is Pramipexole Safe And Effective In Reducing Depressive Symptoms In Patients With Mild To Moderate Parkinson’S Disease And Depression?, Corinne J. Kern
PCOM Physician Assistant Studies Student Scholarship
OBJECTIVE: The objective of this selective EBM review is to determine whether or not pramipexole (Mirapex) is a safe and effective drug to treat depression in patients with mild to moderate Parkinson’s Disease (PD).
STUDY DESIGN: Review of three English language primary randomized controlled trials and one randomized prospective, observational study published between 2003-2010.
DATA SOURCES: Three randomized controlled trials and one randomized prospective, observational study comparing the efficacy of pramipexole to placebo, sertraline (an SSRI) and other dopamine agonists (pergolide) in the treatment of PD related depression symptoms were found using PubMed.
OUTCOME(S) MEASURED: Each of the …
Cosmetic Neurology: Enhancement Of The Mind And Attention Deficit Hyperactive Disorder Medication Abuse Among College Students, Mary M. Huff
Cosmetic Neurology: Enhancement Of The Mind And Attention Deficit Hyperactive Disorder Medication Abuse Among College Students, Mary M. Huff
Senior Honors Theses
Cosmetic neurology is becoming increasingly popular, and it is not just sleep deprived, over worked college students who are interested. People are beginning to seek off-label prescriptions for medications that are typically used to treat disorders such as attention deficit hyperactive disorder (ADHD) or narcolepsy, while researchers are trying to create drugs used solely for mind enhancement purposes. Along with these drugs come many legal and ethical quandaries relating to the regulation of current use as well as the what ifs of future possibilities. A survey was conducted among college students regarding the diagnosis of ADHD, the abuse of ADHD …
Switching And Selecting Atypical Antipsychotic Drugs: Quetiapine, Amresh Srivastava
Switching And Selecting Atypical Antipsychotic Drugs: Quetiapine, Amresh Srivastava
Psychiatry Presentations
No abstract provided.